MedTrace Logo

Gonadal Toxicity in Women With Hodgkin Lymphoma

NCT01008735 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2009-11-13

No results posted yet for this study

Summary

The Gruppo Italiano Studio Linfomi has been collecting data on patients with Hodgkin Lymphoma (HL) since 1988. This archive represents a homogeneous series of consecutive patients with HL. The very long follow up and the availability of clinical and treatment data make it feasible to perform a study on the gonadal toxicity related to treatment for HL.

Conditions

Sponsors & Collaborators

  • Gruppo Italiano Studio Linfomi

    lead OTHER

Principal Investigators

  • Francesco Angrilli, MD · GISL

  • Simona Falorio, MD · GISL

  • Massimo Federico, MD · GISL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01008735 on ClinicalTrials.gov